Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Cell Line Derived Multi-Gene Predictor of Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer: A Validation Study on US Oncology 02-103 Clinical Trial

  • Kui Shen1,
  • Yuan Qi2,
  • Nan Song1Email author,
  • Chunqiao Tian1,
  • Shara D Rice1,
  • Michael J Gabrin1,
  • Stacey L Brower1,
  • William Fraser Symmans3,
  • Joyce A O’Shaughnessy4,
  • Frankie A Holmes5,
  • Lina Asmar6 and
  • Lajos Pusztai7
BMC Medical Genomics20125:51

DOI: 10.1186/1755-8794-5-51

Received: 19 March 2012

Accepted: 12 November 2012

Published: 16 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
19 Mar 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
28 May 2012 Reviewed Reviewer Report - Maud Starmans
25 Jun 2012 Reviewed Reviewer Report - Jorge Reis-Filho
15 Sep 2012 Author responded Author comments - Nan Song
Resubmission - Version 3
15 Sep 2012 Submitted Manuscript version 3
27 Sep 2012 Reviewed Reviewer Report - Jorge Reis-Filho
2 Oct 2012 Reviewed Reviewer Report - Maud Starmans
19 Oct 2012 Author responded Author comments - Nan Song
Resubmission - Version 4
19 Oct 2012 Submitted Manuscript version 4
Publishing
12 Nov 2012 Editorially accepted
16 Nov 2012 Article published 10.1186/1755-8794-5-51

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Product Development, Precision Therapeutics, Inc
(2)
Department of Bioinformatics and Computational Biology, University of Texas MD Anderson Cancer Center
(3)
Department of Pathology, University of Texas MD Anderson Cancer Center
(4)
Baylor Sammons Cancer Center, Texas Oncology, US Oncology, Baylor-Sammons Cancer Center
(5)
Texas Oncology, US Oncology
(6)
Biostatistics and Medical Writing, US Oncology Research, US Oncology, The Woodlands
(7)
Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center

Advertisement